Key result
Tricuspid ring annuloplasty resulted in a 10.4% 30-day mortality rate compared to 21.4% with De Vega suture annuloplasty in patients with secondary tricuspid regurgitation, with no statistically significant difference (p=0.365).
Why the study?
Secondary tricuspid regurgitation scheduled for left-sided surgery was previously managed conservatively, but tricuspid intervention has become increasingly common.
Does Tricuspid Ring Annuloplasty compared to De Vega suture annuloplasty improve short-term outcomes in patients with secondary tricuspid regurgitation undergoing left-sided cardiac surgery?
Observational (n=62)
No
Does Tricuspid Ring Annuloplasty compared to De Vega suture annuloplasty improve short-term outcomes in patients with secondary tricuspid regurgitation undergoing left-sided cardiac surgery?
Absolute Event Rate: 10.4% vs 21.4%
p-value: p=0.365
In patients with secondary tricuspid regurgitation undergoing left-sided cardiac surgery, both ring annuloplasty and De Vega suture annuloplasty demonstrated comparable short-term mortality and effective reduction in TR grade.
Similar short-term mortality observed; leaves open optimal annuloplasty technique for secondary TR.
Objective: Patients with Secondary Tricuspid Regurgitation (TR) scheduled for left-sided surgery were generally followed conservatively in previous periods, but tricuspid intervention has recently become increasingly common. In this study, we aimed to report the short-term results of tricuspid repair procedures performed in our tertiary university clinic. Materials and Methods: Data of 62 patients who underwent surgery for secondary TR at Balıkesir University Faculty of Medicine Hospital between August 2018 and May 2023 were retrospectively analyzed. Tricuspid repair procedures performed in patients with moderate to severe TR and tricuspid annulus diameter >40 mm who were scheduled for left-sided cardiac surgery were included in the study. Patients operated for primary TR, patients with active endocarditis, patients under 18 years of age, and patients with pregnancy status were excluded. Results: The mean age of the patients included in the study was 63.74 ± 10.2 years, 46 were female (74.2%) and 16 were male (25.8%). 48 patients underwent Tricuspid Ring Annuloplasty (TRA) and 14 patients underwent De Vega suture annuloplasty procedures. Preoperative creatinine value was higher in the De-Vega group (p=0.037). In the intervention according to TR calcification, 87.5% of the patients in the TRA group had severe TR, while this rate was 50% in the De-Vega group and a significant difference was found. (p=0.004) 30-day mortality was 12.9% in total and 10.4% in the Ring annuloplasty group and 21.4% in the De-Vega suture annuloplasty group, but there was no statistically significant difference (p=0.365). Conclusion: In this study, we planned to report the sort-term results of two repair methods of De-Vega and TRA for secondary TR.
No takes yet. Share an insight, caveat, or question.
Dolapoğlu et al. (2025) conducted an observational in Secondary Tricuspid Regurgitation (n=62). Tricuspid Ring Annuloplasty vs. De Vega suture annuloplasty was evaluated on 30-day all-cause mortality (p=0.365). Tricuspid ring annuloplasty resulted in a 10.4% 30-day mortality rate compared to 21.4% with De Vega suture annuloplasty in patients with secondary tricuspid regurgitation, with no statistically significant difference (p=0.365).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: